Answers are grounded in this paper and cite their sources.
Extract Tuberculosis (TB) remains a public health threat in Ukraine with 20 991 persons with TB reported in 2023 and an estimated incidence of 112 per 100 000 persons [1, 2]. Drug-resistance (DR) is of concern: 27% of newly diagnosed TB-infections in Ukraine were caused by Mycobacterium tuberculosis (Mtb) carrying resistance to rifampicin (RIF) or RIF and isoniazid (INH; multidrug-resistant tuberculosis, MDR-TB). Additionally, 27% of these isolates exhibited additional resistance to fluoroquinolones (pre-XDR-TB) or combined fluoroquinolone and bedaquiline (BDQ) and/or linezolid (LZD) resistance, thus classified as extensively drug-resistant TB (XDR-TB) [1].
No takes yet. Share an insight, caveat, or question.
Gröschel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: